Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates US govt voices distress over brutal attack on Telangana student in Indiana In a tragic turn of events, an Indian student faces a grim battle for survival following a vicious… byPallavi MadhirajuNovember 3, 2023